Citations

Clear

3942 citation(s) found for "To, Van".

Modulating limbic circuits in temporal lobe epilepsy: impacts on seizures, memory, mood and sleep
Křemen, Václav , Sladky, Vladimir , Mívalt, Filip , Gregg, Nicholas M. , Brinkmann, Benjamin H. , Balzekas, Irena , Marks, Victoria S. , Lundstrom, Brian N. , Cui, Jie, Alden, Eva , Fields, Julie A. , Crockett, Karla, Adolf, Jindřich , Bilderbeek, Jordan, Hermes, Dora, Miller, Kai J. , Bilderbeek, Jordan , Marks, Victoria S , Kucewicz, Michal, Lundstrom, Brian Nils , St Louis, E K , Croarkin, Paul E , Alden, Eva C, Messina, Steven, Miller, Kai Joshua, Van Gompel, Jamie, Brinkmann, Benjamin H , Kremen, Vaclav , Gregg, Nicholas M , Bilderbeek, Jordan A , Mivalt, Filip , Kucewicz, Michał T. , Cui, Jie , Louis, Erik K. St. , Croarkin, Paul E. , Joseph, Boney , Hermes, Dora , Messina, Steven A. , Gompel, Jamie J. Van , Denison, Timothy , Worrell, Gregory A.

Mayo Clinic

Brain Communications | March 7, 2025 | Volume: 7 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcaf106 | PMID 40196395 Get It

Abstract Temporal lobe epilepsy is a common neurological disease characterized by recurrent seizures that often originate within limbic networks involving amygdala and hippocampus. The limbic network is involved in crucial physiologic functions involving memory, emotion and sleep. Temporal lobe epilepsy is frequently drug-resistant, and people often experience comorbidities related to memory, mood and sleep. Deep brain stimulation targeting the anterior nucleus of the thalamus (ANT-DBS) is an established therapy for temporal lobe epilepsy. However, the optimal stimulation parameters and their impact on memory, mood and sleep comorbidities remain unclear. We used an investigational brain sensing-stimulation implanted device to accurately track seizures, interictal epileptiform spikes (IES), and memory, mood and sleep comorbidities in five ambulatory subjects. Wireless streaming of limbic network local field potentials (LFPs) and subject behaviour were captured on a mobile device integrated with a cloud environment. Automated algorithms applied to the continuous LFPs were used to accurately cataloged seizures, IES and sleep-wake brain state. Memory and mood assessments were remotely administered to densely sample cognitive and behavioural response during ANT-DBS in ambulatory subjects living in their natural home environment. We evaluated the effect of continuous low-frequency and duty cycle high-frequency ANT-DBS on epileptiform activity and memory, mood and sleep comorbidities. Both low-frequency and high-frequency ANT-DBS paradigms reduced seizures. However, continuous low-frequency ANT-DBS showed greater reductions in IES, electrographic seizures and better sleep and memory outcomes. These results highlight the potential of synchronized brain sensing and dense behavioural tracking during ANT-DBS for optimizing neuromodulation therapy. While studies with larger patient numbers are needed to validate the benefits of low-frequency ANT-DBS, these findings are potentially translatable to individuals currently implanted with ANT-DBS systems.
Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge
LaBella, Dominic , Baid, Ujjwal , Khanna, Omaditya , McBurney-Lin, Shan , McLean, Ryan, Rashid, Arif , Altes, Talissa A. , Bhalerao, Radhika , Dhemesh, Yaseen , Hilal, Fathi , Janas, Anastasia , Kazerooni, Anahita Fathi , Kent, Collin , Leu, Kevin , Maleki, Nazanin , Pajot, Maxence , Saluja, Rachit , Wang, Chunhao , Warman, Pranav , Adewole, Maruf , Albrecht, Jake, Anwar, Syed Muhammad , Bergquist, Timothy , Chen, Sully Francis, Conte, Gian-Marco, Eddy, J. Mark , Ezhov, Ivan , Jiang, Zhifan , Johanson, Elaine, Linguraru, Marius George , Liu, Xinyang , Meier, Zeke, Shinohara, Russell Takeshi, Abayazeed, Aly, Akinola, Rachel , Bilello, Michel , Verdier, Maria Correia de, Moassefi, Mana, Pease, Matthew W., Vollmuth, Phillipp, Diffley, David, Hussain, Ali , Fehringer, Pascal, Bronstein, Yulia, Deptula, Lisa, Stein, Evan G. , Taherzadeh, Mahsa , Oliveira, Eduardo Portela de, Haughey, Aoife , Kontzialis, Marinos , Saba, Luca , Turner, Benjamin , Brüßeler, Melanie, Gkampenis, Athanasios , Weiss, David Maximilian, Mansour, Aya, Shawali, Islam H., Yordanov, Nikolay , Hourani, Roula , Moshebah, Mohammed Yahya, Abouelatta, Ahmed Magdy, Willms, Klara, Martin, Dann C., Okar, Abdullah , Kite, Dominic , Haider, Muhammad Ammar , Aristizábal, Alejandro , Karargyris, Alexandros , Kassem, Hasan , Sheller, Micah , Alonso‐Basanta, Michelle , McLean, Ryan, Nedelec, Pierre , Rashid, Arif, Tahon, Nourel Hoda , Godfrey, Devon , Floyd, Scott , Kirkpatrick, John P. , Kofler, Florian , Menze, Bjoern H. , Reitman, Zachary J. , Rudie, Jeffrey D. , Velichko, Yury , Anazodo, Udunna , Chung, Verena , Chai, Rong, Dako, Farouk , Eddy, James, Khalili, Nastaran , Iglesias, Juan Eugenio , Leemput, Koen Van , Li, Hongwei , Mahtabfar, Aria , Moawad, Ahmed W. , Mongan, John , Piraud, Marie , Shinohara, Russell Taki , Wiggins, Walter F. , Jakab, András Áron , Verdier, Maria Correia de , Crivellaro, Priscila Sacilotto , Davatzikos, Christos , Farahani, Keyvan , Freymann, John , Hess, Christopher Paul , Huang, Raymond Y. , Lohmann, Philipp , Moassefi, Mana , Sollmann, Nico , Nandolia, Khanak , Warren, Daniel I, Saba, Luca , Ansari, Shehbaz , Stein, Joel M. , Rizvi, Tanvir , D’Anna, Gennaro , Taha, Ahmed , Sharifi, Yasaman , Faghani, Shahriar , Pinho, Marco C. , Pati, Sarthak , Villanueva-Meyer, Javier E. , Rauschecker, Andreas M. , Nada, Ayman , Aboian, Mariam , Flanders, Adam E , Wiestler, Benedikt , Bakas, Spyridon , Calabrese, Evan

Mayo Clinic

Machine Learning for Biomedical Imaging | March 7, 2025 | Volume: 3 | Issue: March 2025 | Pages: 38-58

10.59275/j.melba.2025-bea1 Get It

We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas, which are typically benign extra-axial tumors with diverse radiologic and anatomical presentation and a propensity for multiplicity. Nine participating teams each developed deep-learning automated segmentation models using image data from the largest multi-institutional systematically expert annotated multilabel multi-sequence meningioma MRI dataset to date, which included 1000 training set cases, 141 validation set cases, and 283 hidden test set cases. Each case included T2, FLAIR, T1, and T1Gd brain MRI sequences with associated tumor compartment labels delineating enhancing tumor, non-enhancing tumor, and surrounding non-enhancing FLAIR hyperintensity. Participant automated segmentation models were evaluated and ranked based on a scoring system evaluating lesion-wise metrics including dice similarity coefficient (DSC) and 95% Hausdorff Distance. The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor, respectively and a corresponding average DSC of 0.899, 0.904, and 0.871, respectively. These results serve as state-of-the-art benchmarks for future pre-operative meningioma automated segmentation algorithms. Additionally, we found that 1286 of 1424 cases (90.3%) had at least 1 compartment voxel abutting the edge of the skull-stripped image edge, which requires further investigation into optimal pre-processing face anonymization steps.
Brain aging shows nonlinear transitions, suggesting a midlife “critical window” for metabolic intervention
Antal, Botond , Nieuwenhuizen, Helena van , Jones, David T. , Clarke, Kieran , Weistuch, Corey , Ratai, Eva‐Maria , Dill, Ken A. , Mujica‐Parodi, Lilianne R. , Jones, David T , Dill, Ken A , Mujica-Parodi, Lilianne R , Chesebro, Anthony G. , Strey, Helmut H.

Mayo Clinic

Proceedings of the National Academy of Sciences | March 3, 2025 | Volume: 122 | Issue: 10 | Pages: No page available

10.1073/pnas.2416433122 | PMID 40030017 Get It

Understanding the key drivers of brain aging is essential for effective prevention and treatment of neurodegenerative diseases. Here, we integrate human brain and physiological data to investigate underlying mechanisms. Functional MRI analyses across four large datasets (totaling 19,300 participants) show that brain networks not only destabilize throughout the lifetime but do so along a nonlinear trajectory, with consistent temporal “landmarks” of brain aging starting in midlife (40s). Comparison of metabolic, vascular, and inflammatory biomarkers implicate dysregulated glucose homeostasis as the driver mechanism for these transitions. Correlation between the brain’s regionally heterogeneous patterns of aging and gene expression further supports these findings, selectively implicating GLUT4 (insulin-dependent glucose transporter) and APOE (lipid transport protein). Notably, MCT2 (a neuronal, but not glial, ketone transporter) emerges as a potential counteracting factor by facilitating neurons’ energy uptake independently of insulin. Consistent with these results, an interventional study of 101 participants shows that ketones exhibit robust effects in restabilizing brain networks, maximized from ages 40 to 60, suggesting a midlife “critical window” for early metabolic intervention.
Safe and efficacious therapeutic outcomes with salvage endonasal transsphenoidal surgery for pituitary adenoma progression following stereotactic radiosurgery
Shinya, Yuki , Hong, Sukwoo , Erickson, Dana , Wipplinger, Tamara , Palit, Sandhya R. , Shin, Masahiro , Link, Michael J. , Pollock, Bruce E., Atkinson, John L. D., Wipplinger, Christoph , Herndon, Justine S, Wipplinger, Tamara M, Shinya, Yuki , Hasegawa, Hirotaka , Bancos, Irina , Herndon, Justine , Shin, Masahiro, Saito, Nobuhito , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | February 28, 2025 | Volume: 143 | Issue: 1 | Pages: 165-173

10.3171/2024.10.jns241682 | PMID 40020238 Get It

OBJECTIVE Stereotactic radiosurgery (SRS) offers excellent tumor control for pituitary adenoma (PA); however, treatment failure occasionally necessitates salvage surgery. Comprehensive studies on salvage surgical outcomes for recurrent PA after SRS remain scarce. This study aimed to elucidate the outcomes of salvage endonasal transsphenoidal surgery (sETS) for progressive PA failing SRS. METHODS This retrospective, two institution–based cohort study analyzed data from patients who underwent sETS for progressive PA failing SRS. Progression-free survival (PFS), disease-specific survival (DSS), and neurological and endocrinological outcomes in the sETS group were analyzed and compared with those in the primary ETS (pETS) group after propensity score matching using the following variables: age at surgery, maximum tumor diameter, highest Knosp–Steiner classification, and tumor type. RESULTS Thirteen sETS patients (8 males [62%], median age at surgery of 56 years) with 5 nonfunctioning (39%), 6 corticotropic (46%), and 2 other functioning (15%) PAs who received median (range) follow-up of 125 ( 23–169) months were included. None of the patients experienced new neurological deficits or death after sETS. The median (range) tumor resection rate was 90% (80%–100%). The 5-year PFS and DSS rates were 55% and 77%, respectively. All 4 patients (31%) who experienced recurrence after sETS had corticotropic tumors. In the matched cohort analysis between the sETS group with 12 patients and the pETS group with 12 patients, no significant differences were observed in surgical outcomes. PFS rates were marginally higher in the sETS group than in the pETS group (80% vs 49% at 3 years, p = 0.216, log-rank test), and DSS was similar between the two groups (p = 0.543, log-rank test). CONCLUSIONS The authors’ results indicate that ETS can be safely performed as a salvage treatment after failed SRS with low complication rates and satisfactory tumor control in treatment-resistant PA.
Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality
Arafa, Ali T., Yadav, Siddhartha , Marshall, Catherine H. , Mauer, Elizabeth , Huang, Minxuan , Yilma, Binyam , Pol, Ymke van der , Fragkogianni, Stamatina , Teslow, Emily A. , Kellen, Samuel , Boytim, Ella , Luo, Christine , Ludwig, Megan , Jayaraj, Arockia, Armstrong, Deborah K. , Isaacs, William B. , Nguyen, Hai Dang , Huang, R. Stephanie , Dehm, Scott M. , Hwang, Justin H. , Arafa, Ali T. , Arafa, Ali , van der Pol, Ymke , Zhang, Weijie , Jayaraj, Arockia , Armstrong, Deborah K , Isaacs, William B , Drake, Justin M , Nguyen, Hai Dang , Huang, R Stephanie , Chao, Calvin Y. , Lou, Emil , Dehm, Scott M , Couch, Fergus J. , Hwang, Justin H , Antonarakis, Emmanuel S , Mauer, Elizabeth , Yadav, Siddhartha , Marshall, Catherine H , Teslow, Emily A , Fragkogianni, Stamatina , Lou, Emil , Couch, Fergus J. , Antonarakis, Emmanuel S.

Mayo Clinic

Clinical Cancer Research | February 28, 2025 | Volume: 31 | Issue: 9 | Pages: 1730-1745

10.1158/1078-0432.ccr-24-2058 | PMID 40019487 Get It

Abstract Purpose: Germline alterations in homologous recombination repair (gHRR) genes affect the pathogenesis, treatment options, and survival of patients with cancer. However, distinct gHRR gene alterations may differentially affect treatment response and oncogenic signaling. In this study, we interrogated genomic and transcriptomic data and assessed clinical outcomes of patients with gHRR mutations across four BRCA-associated cancers (breast, ovarian, pancreatic, and prostate cancers) to identify therapeutic vulnerabilities. Experimental Design: We assessed 24,309 patients undergoing matched tumor/normal next-generation DNA and RNA sequencing. Annotated gHRR gene variants [germline BRCA1, germline BRCA2, germline PALB2, germline ATM (gATM), and germline CHEK2] were analyzed. HRs were used to assess survival outcomes comparing germline versus sporadic groups. Somatic alterations and their frequencies were compared across gHRR-altered groups. Differential gene expression and gene set enrichment analysis were used to compare transcriptomic profiles. Results: Somatic TP53 mutations were depleted in gATM carriers (P < 0.05) across all four BRCA-associated cancers by up to 2.5-fold. Tumors with germline BRCA1/2 mutations were associated with improved survival in patients with ovarian cancer and had consistent enrichment of TP53 mutations in all four cancers. gATM mutations displayed elevated p53 transcriptional activity in all four cancers, with significance reached in breast and prostate cancers (P < 0.01). In breast, ovarian, and prostate cancers, gATM tumors demonstrated significantly increased inflammatory pathways (P < 0.001). Finally, using gene dependency data, we found that cell lines that were highly dependent on ATM were co-dependent on canonical p53 function. Conclusions: gATM-associated cancers seem to require intact p53 activity and this synthetic essentiality may be used to guide targeted therapies that perturb canonical TP53 function.
Escalation of Oxygenation Modalities and Mortality in Critically Ill Immunocompromised Patient With Acute Hypoxemic Respiratory Failure: A Clustering Analysis of a Prospectively Multicenter, Multinational Dataset
Yvin, Élise, Kouatchet, Achille, Mokart, Djamel, Martín‐Loeches, Ignacio , Seguin, Amélie, Louw, Andry van de, Mabrouki, Asma, Bredin, Swann, Klouche, Kada , Mehta, Sangeeta , Bruneel, Fabrice , Lisboa, Tiago, Viana, William, Pickkers, Peter , Russell, Lene , Rusínová, Kateřina , Rello, Jordi, Clère-Jehl, Raphaël , Lafarge, Antoine , Lemiale, Virginie , Mercat, Alain , Russell, Lene , Martin-Loeches, Ignacio , Kouatchet, Achille, Mokart, Djamel , Taccone, Fabio Silvio , Pène, Frédéric , Bauer, Philippe R. , Seguin, Amélie, Metaxa, Victoria , Montini, Luca , Lisboa, Tiago, Rello, Jordi , Barbier, Francois, Azoulay, Élie , Darmon, Michaël

Mayo Clinic

Critical Care Medicine | February 27, 2025 | Volume: 53 | Issue: 5 | Pages: e1055-e1065

10.1097/ccm.0000000000006600 | PMID 40013850 Get It

OBJECTIVES: Acute hypoxemic respiratory failure in immunocompromised patients remains the leading cause of admission to the ICU, with high case fatality. The response to the initial oxygenation strategy may be predictive of outcome. This study aims to assess the response to the evolutionary profiles of oxygenation strategy and the association with survival. DESIGN: Post hoc analysis of EFRAIM study with a nonparametric longitudinal clustering technique (longitudinal K-mean). SETTING AND PATIENTS: Multinational, observational prospective cohort study performed in critically ill immunocompromised patients admitted for an acute respiratory failure. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 1547 patients who did not require invasive mechanical ventilation (iMV) at ICU admission were included. Change in ventilatory support was assessed and three clusters of change in oxygenation modality over time were identified. Cluster A: 12.3% iMV requirement and high survival rate, n = 717 patients (46.3%); cluster B: 32.9% need for iMV, 97% ICU mortality, n = 499 patients (32.3%); and cluster C: 37.5% need for iMV, 0.3% ICU mortality, n = 331 patients (21.4%). These clusters demonstrated a high discrimination. After adjustment for confounders, clusters B and C were independently associated with need for iMV (odds ratio [OR], 9.87; 95% CI, 7.26–13.50 and OR, 19.8; 95% CI, 13.7–29.1). CONCLUSIONS: This study identified three distinct highly performing clusters of response to initial oxygenation strategy, which reliably predicted the need for iMV requirement and hospital mortality.
Ditching the defaults: Assessing the impact of default duration removal on antibiotic prescriptions originating in the emergency department
Abel, A. L. , Stevens, Ryan W. , Ausman, Sara , Hannan, Kellie N. Arensman , Ilges, Dan , Kooda, Kirstin , Lessard, Sarah , Willis, Courtney , Jensen, Kelsey , Van Abel, Amy L , Arensman Hannan, Kellie , Willis, Courtney M , Jensen, Kelsey , Ausman, Sara E , Stevens, Ryan W , Ilges, Dan , Rivera, Christina G.

Mayo Clinic

Infection Control & Hospital Epidemiology | February 24, 2025 | Volume: 46 | Issue: 5 | Pages: 548-550

10.1017/ice.2025.31 | PMID 39989314 Get It

Abstract Reducing antimicrobial exposure by limiting the duration of therapy is an effective antimicrobial stewardship strategy. In this article, we describe the impact of modification of the electronic health record to remove default durations of therapy on ambulatory antibiotic prescriptions issued from emergency departments in a large, multicenter health system.
Characteristics of Patients With the Arrhythmogenic Mitral Valve Prolapse Syndrome and Sudden Cardiac Arrest and Sustained Ventricular Arrhythmias
Chakrabarti, Apurba , Giudicessi, John R. , Delling, Francesca N. , Dixit, Shalini , Lee, Yoo Jin , Muser, Daniele , Magnani, Silvia , Wijngaarden, Aniek L. van , Miller, Marc A. , Gandhi, Jonathan, Font, Jonaz , Martins, Raphaël P. , McCaffrey, James A. , Chapagain, Himal , Mathew, Don , Kancharla, Krishna , Syed, Faisal F. , Abid, Ahad, Cerbin, Lukasz , Garg, Lohit , Natale, Andrea , Enríquez, Andrés , Bogun, Frank , Ackerman, Michael J. , Liang, Jackson J. , Ezzeddine, Fatima , Delling, Francesca N , Lee, Yoo Jin , Muser, Daniele , Magnani, Silvia , van Wijngaarden, Aniek , Marsan, Nina Ajmone , Trivieri, Maria G , Font, Jonaz , Martins, Raphael , McCaffrey, James A , Santangeli, Pasquale , Marchlinski, Francis E , Chapagain, Himal , Mathew, Don , Kancharla, Krishna , Syed, Faisal F , Abid, Ahad , Tzou, Wendy , Della Rocca, Domenico G , Natale, Andrea , Mohanty, Sanghamitra , Sheldon, Seth H. , Kuo, Ling , Haugaa, Kristina , Aabel, Eivind W , Enriquez, Andres , Maeda, Shingo , Deshmukh, Amrish , Ackerman, Michael J , Liang, Jackson , Ezzeddine, Fatima M. , Marsan, Nina Ajmone , Santangeli, Pasquale , Marchlinski, Francis E. , Tzou, Wendy S. , Rocca, Domenico G. Della , Haugaa, Kristina H. , Aabel, Eivind W. , Deshmukh, Amrish , Ghannam, Michael

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 20, 2025 | Volume: 18 | Issue: 3 | Pages: No page available

10.1161/circep.124.013099 | PMID 39973752 Get It

BACKGROUND: Patients with arrhythmogenic mitral valve prolapse syndrome are at increased risk for life-threatening ventricular arrhythmias, but studies have been limited by small sample sizes. We sought to assemble an international arrhythmogenic mitral valve prolapse syndrome registry to delineate the clinical, imaging, and treatment characteristics of patients with arrhythmogenic mitral valve prolapse syndrome who survived sudden cardiac arrest (SCA) or had sustained ventricular tachycardia (VT) or ventricular fibrillation. METHODS: In this descriptive registry, we characterized patients with arrhythmogenic mitral valve prolapse syndrome who survived SCA, sustained VT, or ventricular fibrillation. Deidentified data were abstracted locally and combined centrally. RESULTS: We included 148 patients who had SCA or VT/ventricular fibrillation. Patients had a mean age of 43.7±15.4 years; 68% were women, 73% had bileaflet prolapse, 65% had mitral annular disjunction, 67% had nonsustained VT, and 59% had inferolateral T-wave inversions. Syncope (n=54, 48%) and anterolateral T-wave inversion (n=26, 22%) were relatively common. Catheter ablation was performed in 50 (35%) patients for premature ventricular complexes and in 18 (17.7%) patients for VT. Sites of origin for arrhythmias were commonly in the papillary muscles, fascicles, mitral annulus, and inferior/inferolateral left ventricle. CONCLUSIONS: In this international descriptive registry of patients with arrhythmogenic mitral valve prolapse syndrome and SCA, patients were young, women, and had bileaflet mitral valve prolapse, mitral annular disjunction, inferolateral T-wave inversions, and nonsustained VT. A history of syncope and anterolateral T-wave inversions was relatively common in patients who survived SCA or sustained VT/ventricular fibrillation.
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts
Pal, Sumanta K. , Loriot, Yohann , Necchi, Andrea , Singh, Parminder , Castellano, Daniel , Pagliaro, Lance C. , Suárez, Cristina , McGregor, Bradley A. , Vaishampayan, Ulka N. , Hauke, Ralph J. , Herpen, Carla M.L. van , Sudhagoni, Ramu, Schwickart, Martin, Andrianova, Svetlana, Powles, Thomas , Van Herpen, Carla M L , Courtney, Kevin D , Dreicer, Robert , Agarwal, Archana M , Necchi, Andrea , McGregor, Bradley , Vaishampayan, Ulka , Loriot, Yohann , Singh, Parminder , Dreicer, Robert , Agarwal, Neeraj

Mayo Clinic

Journal of Clinical Oncology | February 18, 2025 | Volume: 43 | Issue: 14 | Pages: 1650-1662

10.1200/jco-24-01675 | PMID 39965176 Get It

PURPOSE The COSMIC-021 study assessed the safety and efficacy of cabozantinib plus atezolizumab in advanced solid tumors. Presented here are results from the expansion cohorts with advanced urothelial carcinoma (UC). METHODS This phase Ib study (ClinicalTrials.gov identifier: NCT03170960 ) enrolled patients with inoperable locally advanced/metastatic UC into four tumor cohorts: first-line cisplatin-eligible (cis-eligible), first-line cisplatin-ineligible (cis-ineligible), previous platinum-containing chemotherapy (previous chemotherapy-treated), and previous immune checkpoint inhibitor (ICI)–treated. Patients received oral cabozantinib 40 mg once daily and intravenous atezolizumab 1,200 mg once every 3 weeks. The primary end point was objective response rate (ORR), as assessed by the investigator per RECIST v1.1 every 6 weeks for 12 months and every 12 weeks thereafter; the secondary end point was safety. RESULTS A total of 121 patients (previous ICI-treated cohort, n = 31, and each of the other cohorts, n = 30) received study treatment from March 2018 to November 2021. The ORR (95% CI) was 30% (15 to 49) for cis-eligible, 20% (8 to 39) for cis-ineligible, 27% (12 to 46) for previous chemotherapy-treated, and 10% (2 to 26) for previous ICI-treated cohorts. The median progression-free survival (95% CI) was 5.5 (1.6 to 11.6), 5.6 (3.1 to 11.1), 5.4 (1.6 to 7.6), and 3.0 (1.8 to 5.5) months, respectively. Grade 3 or 4 treatment-related adverse events (TRAEs) were experienced by 43%, 67%, 57%, and 45% of patients, respectively. TRAEs led to discontinuation of all treatment components in 17%, 13%, 3%, and 19%, respectively. No grade 5 TRAEs were reported in any cohort. CONCLUSION The novel combination of cabozantinib plus atezolizumab exhibited clinical activity in advanced UC that is cis-eligible, cis-ineligible, or previously treated with platinum-containing chemotherapy; clinical activity in previous ICI-treated UC was modest. The toxicity profile was consistent with that previously reported for the combination.